232 related articles for article (PubMed ID: 20795789)
1. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
Valencia A; Román-Gómez J; Cervera J; Such E; Barragán E; Bolufer P; Moscardó F; Sanz GF; Sanz MA
Leukemia; 2009 Sep; 23(9):1658-66. PubMed ID: 19387464
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
[TBL] [Abstract][Full Text] [Related]
4. Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia.
Cheng CK; Li L; Cheng SH; Ng K; Chan NP; Ip RK; Wong RS; Shing MM; Li CK; Ng MH
Blood; 2011 Dec; 118(25):6638-48. PubMed ID: 22031861
[TBL] [Abstract][Full Text] [Related]
5. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas.
Götze S; Wolter M; Reifenberger G; Müller O; Sievers S
Int J Cancer; 2010 Jun; 126(11):2584-93. PubMed ID: 19847810
[TBL] [Abstract][Full Text] [Related]
6. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia.
Román-Gómez J; Cordeu L; Agirre X; Jiménez-Velasco A; San José-Eneriz E; Garate L; Calasanz MJ; Heiniger A; Torres A; Prosper F
Blood; 2007 Apr; 109(8):3462-9. PubMed ID: 17148581
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
Chim CS; Pang R; Liang R
J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
[TBL] [Abstract][Full Text] [Related]
9. Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia.
Hou HA; Kuo YY; Liu CY; Lee MC; Tang JL; Chen CY; Chou WC; Huang CF; Lee FY; Liu MC; Yao M; Tien HF
Br J Cancer; 2011 Dec; 105(12):1927-33. PubMed ID: 22095226
[TBL] [Abstract][Full Text] [Related]
10. Methylation analysis of SFRP genes family in cervical adenocarcinoma.
Lin YW; Chung MT; Lai HC; De Yan M; Shih YL; Chang CC; Yu MH
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1665-74. PubMed ID: 19513747
[TBL] [Abstract][Full Text] [Related]
11. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
[TBL] [Abstract][Full Text] [Related]
12. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW
Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
Chim CS; Pang R; Fung TK; Choi CL; Liang R
Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma.
Takagi H; Sasaki S; Suzuki H; Toyota M; Maruyama R; Nojima M; Yamamoto H; Omata M; Tokino T; Imai K; Shinomura Y
J Gastroenterol; 2008; 43(5):378-89. PubMed ID: 18592156
[TBL] [Abstract][Full Text] [Related]
15. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
[TBL] [Abstract][Full Text] [Related]
16. Concurrent Evaluation of the Expression and Methylation of
Mirzaeyan F; Chahardouli B; Mirzaeian A; Alizad Ghandforoush N; Alimoghaddam K; Rostami S
Iran J Med Sci; 2021 May; 46(3):180-188. PubMed ID: 34083850
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells.
Masala E; Valencia A; Buchi F; Nosi D; Spinelli E; Gozzini A; Sassolini F; Sanna A; Zecchi S; Bosi A; Santini V
Leuk Res; 2012 Oct; 36(10):1290-5. PubMed ID: 22742816
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD
Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894
[TBL] [Abstract][Full Text] [Related]
19. DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer.
Zhu J; Wang Y; Duan J; Bai H; Wang Z; Wei L; Zhao J; Zhuo M; Wang S; Yang L; An T; Wu M; Wang J
J Exp Clin Cancer Res; 2012 Sep; 31(1):80. PubMed ID: 23009178
[TBL] [Abstract][Full Text] [Related]
20. [Application of Bisulfite Sequencing PCR in Detecting the Abnormal Methylation of Suppressor Gene of Wnt Signaling Pathway in Acute Promyelocytic Leukemia].
Yan JG; Fu HY; Shen JZ; Zhou HR; Zhang YY; Huang JL; Chen CJ; Huang SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1299-1304. PubMed ID: 27784346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
